Boston Scientific claims patent victory Irish Times Johnson & Johnson in the 2008 suit alleged that BostonScientific's Promus Everolimus-Eluting Coronary Stent System infringed two patents, known as the Morris patents, relating to the use of the drug on the stent. |
